Skip to main content

Table 7 Responder Estimates for ASDD Axillary Sweating Severity Item (Item 2): Anchor-Based Method (Phase 2 Data)

From: Development and validation of the Axillary Sweating Daily Diary: a patient-reported outcome measure to assess axillary sweating severity

PGIC Response

Phase 2: DRM04-HH02

(N = 105)

Phase 3 Pooled: ATMOS-1 & ATMOS-2

(N = 697)

n (%)

ASDD Axillary Sweating Severity (Average Weekly Change),

mean ± SD [median]

n (%)

HDSS change score

(Average Weekly Change), mean ± SD [median]

n (%)

ASDD Axillary Sweating Severity (Average Weekly Change),

mean ± SD [median]

n (%)

HDSS change score

(Average Weekly Change), mean ± SD [median]

1 = Much better

50 (64.1)

− 5.1 ± 2.5 [− 5.5]

45

− 1.9 ± 0.80 [− 2.0]

276 (39.6)

−5.7 ± 2.05 [− 5.7]

276 (39.6)

− 2.0 ± 0.71 [− 2.0]

2 = Moderately better

11 (14.1)

− 3.8 ± 2.7 [− 3.4]

10

− 1.5 ± 0.71 [− 1.0]

111 (15.9)

− 3.8 ± 2.28 [− 3.7]

111 (15.9)

− 1.4 ± 0.66 [− 1.0]

3 = A little better

13 (16.7)

− 2.3 ± 1.2 [− 1.9]

14

− 0.6 ± 0.76 [0.0]

119 (17.1)

− 2.3 ± 1.97 [− 1.9]

119 (17.1)

− 0.9 ± 0.71 [− 1.0]

4 = No difference

4 (5.1)

− 1.7 ± 0.7 [− 1.9]

3

−0.3 ± 0.58 [0.0]

82 (11.8)

−1.0 ± 1.69 [−0.6]

82 (11.8)

−0.5 ± 0.74 [0.0]

5 = A little worse

0

0

11 (1.6)

0.2 ± 1.54 [0.3]

11 (1.6)

−0.4 ± 0.67 [0.0]

6 = Moderately worse

0

0

0

0

7 = Much worse

0

0

0

0

  1. Bold text represents the preferred threshold for meaningful response consistent with FDA guidance (“moderately better”)
  2. ASDD Axillary Sweating Daily Diary, PGIC Patient Global Impression of Change, SD Standard deviation